Delivery Order SPE2DB24D1034-SPE2DB24FVYA7
Award Date 2/20/24
Potential Completion Date 2/21/24
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,061.92 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
- This federal contract award, valued at $1,746.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUCRISA 2% ointment in 60 gram quantities, with an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award, valued at $2,114.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUCRISA 2% ointment, a pharmaceutical product, with a performance period through May 2024. The contract was awarded as a Firm Fixed Price Delivery Order and did not utilize any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
- This federal contract award, valued at $1,493.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of EUCRISA 2% ointment, a pharmaceutical product, with a completion date of April 2, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,201.67, is for the delivery of EUCRISA 2% ointment 60GM. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
- This federal contract award, with an ID of SPE2DB24D3013|SPE2DB25FFGJU, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,355.44, is for the delivery of the pharmaceutical product EUCRISA 2% Ointment in 60-gram quantities. The contract is a Firm Fixed Price Delivery Order with a completion date of November 12, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- This federal contract award, with a ceiling value of $3,629.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), is for the provision of EUCRISA 2% ointment, a prescription medication. The contract has a period of performance through November 28, 2023 and utilizes a firm fixed-price pricing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.59 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a topical medication, with a performance period ending on May 20, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of EUCRISA 2% ointment in 60 gram quantities. The $2,555.05 firm fixed-price delivery order contract is non-set-aside and was awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain. The contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,078.09 firm fixed-price delivery order contract is for the provision of 4566629016 EUCRISA 2% OINTMENT 100GM, with a completion date of December 6, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...